Lv41
588 积分 2024-07-07 加入
Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension
18天前
已完结
New drug therapies for hypertension
19天前
已完结
Shenfu injection prevents sepsis-induced myocardial injury by inhibiting mitochondrial apoptosis
1个月前
已完结
Shenfu, traditional Chinese medicine in sepsis: are we ready for it?
1个月前
已完结
Tenecteplase for Acute Non–Large Vessel Occlusion 4.5 to 24 Hours After Ischemic Stroke
2个月前
已完结
Thrombolysis With the Non-Immunogenic Staphylokinase for Acute Ischemic Stroke in the FORPI Registry: An Observational Study
2个月前
已完结
Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trial
2个月前
已完结
Intracoronary Low-Dose Recombinant Tissue Plasminogen Activator in Primary PCI for ST-Segment Elevation Myocardial Infarction and Large Thrombus Burden
2个月前
已关闭
Endotype trajectories: better understanding for better sepsis management
2个月前
已完结
Current status of immunomodulatory therapies in adult sepsis patients: where do we stand?
2个月前
已完结
皖公网安备34019202002308
